Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate

Monique E. Hinchcliff*, Jon Lomasney, Julie A. Johnson, John Varga

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)1916-1918
Number of pages3
JournalRheumatology (United Kingdom)
Volume55
Issue number10
DOIs
StatePublished - Oct 1 2016

Funding

This work was supported by the National Institutes of Health [K23 AR059763, R21 AR068035 to M.H.); and the Scleroderma Research Foundation to M.H. Novartis funded the clinical trial but was not involved in the preparation of this correspondence. No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript.

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Rheumatology

Cite this